Skip to content
Cybin episode artwork

Jun 9, 2021 8 min

Cybin

from OTCQB Podcast Hosted by OTC Markets Group

Cybin (OTCQB: CLXPF) is a life sciences company at the forefront of the revolution in mental health therapeutics and is developing a new class of psychedelic medicines and treatment protocols, with the goal of becoming the leader in psychedelic therapeutics for mental well-being. CEO Douglas Drysdale joins us to discuss the company's unique and non-traditional approach to treat mental and neurological disorders. View Podcast Transcript for Cybin Inc

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Cybin

0:00 8:37

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 8 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on June 9, 2021.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.